scholarly journals A sequence-dependent classification algorithm for Crohn’s Disease – causing NOD2 protein mutations

2020 ◽  
Vol 19 (1) ◽  
pp. 52-60
Author(s):  
Jose Isagani B. Janairo ◽  
Marianne Linley L. Sy-Janairo

Certain NOD2 protein mutations have been associated with the onset of the inflammatory bowel disease, Crohn’s Disease (CD). NOD2 is involved in the inflammatory response of the gut to the microbial community, wherein its functional impairment through mutations may lead to CD progression. Considering the significant role that NOD2 plays in CD pathogenesis, predicting whether a specific type of NOD2 mutation is the cause of CD can greatly aid the accuracy of the disease diagnosis. Hence, a novel sequence-based classification algorithm built on artificial neural network (ANN) is herein presented that can predict whether a specific NOD2 mutation can cause CD or not. The NOD2 mutant types and their association with CD were taken from literature, and the calculated sequence-order coupling numbers were used as the classification predictors. The formulated ANN classifier exhibited satisfactory predictive ability, with 82.4 % accuracy, 62.5 % sensitivity, 100 % specificity, 100 % positive predictive value, and 75 % negative predictive value. The presented ANN classifier provides a proof-of-concept that predicting the onset of CD from NOD2 protein variant is possible.

2012 ◽  
Vol 142 (5) ◽  
pp. S-579-S-580 ◽  
Author(s):  
Gionata Fiorino ◽  
Laurent Biroulet ◽  
Patrizia Naccarato ◽  
Chiara De Cassan ◽  
Cristiana Bonifacio ◽  
...  

2021 ◽  
Author(s):  
Kristyna Zarubova ◽  
Ondrej Fabian ◽  
Ondrej Hradsky ◽  
Tereza Lerchova ◽  
Filip Mikus ◽  
...  

2015 ◽  
Vol 21 (22) ◽  
pp. 6952-6964 ◽  
Author(s):  
Nora Sipeki ◽  
Laszlo Davida ◽  
Eszter Palyu ◽  
Istvan Altorjay ◽  
Jolan Harsfalvi ◽  
...  

2014 ◽  
Vol 8 (9) ◽  
pp. 1022-1029 ◽  
Author(s):  
Graham D. Naismith ◽  
Lyn A. Smith ◽  
Sarah J.E. Barry ◽  
Joanna I. Munro ◽  
Susan Laird ◽  
...  

Abstract Background Faecal calprotectin (FC) is a non-invasive marker of gastrointestinal inflammation. Aim To determine whether higher FC levels in individuals with quiescent Crohn's disease are associated with clinical relapse over the ensuing 12 months. Methods A single centre prospective study was undertaken in Crohn's disease patients in clinical remission. The receiver operating characteristic (ROC) curve for the primary endpoint of clinical relapse by 12 months, based on FC at baseline, was calculated. Kaplan–Meier curves of time to relapse were based on the resulting optimal FC cutoff for predicting relapse. Results Of 97 patients recruited, 92 were either followed up for 12 months without relapsing, or reached the primary endpoint within that period. Of these, 10 (11%) relapsed by 12 months. Median FC was lower for non-relapsers, 96 μg/g (IQR 39–237), than for relapsers, 414 μg/g (IQR 259–590), (p = 0.005). The area under the ROC curve to predict relapse using FC was 77.4%. An optimal cutoff FC value of 240 μg/g to predict relapse had sensitivity of 80.0% and specificity of 74.4%. Negative predictive value was 96.8% and positive predictive value was 27.6%, FC ≥ 240 μg/g was associated with likelihood of relapse by 12-months 12.18 (95%CI 2.55–58.2) times higher than lower values (p = 0.002). Conclusions In this prospective dataset, FC is a useful tool to help identify quiescent Crohn's disease patients at a low risk of relapse over the ensuing 12 months. FC of 240 μg/g was the optimal cutoff in this cohort.


Sign in / Sign up

Export Citation Format

Share Document